{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:10Z","timestamp":1787026330175,"version":"build-2736575974"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["20-15-00353"],"award-info":[{"award-number":["20-15-00353"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease associated with morbidity and mortality at any age. As studies in recent decades have shown, the genetic architecture of HCM is quite complex both in the entire population and in each patient. In the rapidly advancing era of gene therapy, we have to provide a detailed molecular diagnosis to our patients to give them the chance for better and more personalized treatment. In addition to emphasizing the importance of genetic testing in routine practice, this review aims to discuss the possibility to go a step further and create an expanded genetic panel that contains not only variants in core genes but also new candidate genes, including those located in deep intron regions, as well as structural variations. It also highlights the benefits of calculating polygenic risk scores based on a combination of rare and common genetic variants for each patient and of using non-genetic HCM markers, such as microRNAs that can enhance stratification of risk for HCM in unselected populations alongside rare genetic variants and clinical factors. While this review is focusing on HCM, the discussed issues are relevant to other cardiomyopathies.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1236539","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T16:51:36Z","timestamp":1690822296000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow"],"prefix":"10.3389","volume":"10","author":[{"given":"Olga S.","family":"Chumakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia M.","family":"Baulina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4,111 subjects in the CARDIA study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular genetic basis of hypertrophic cardiomyopathy","volume":"128","author":"Marian","year":"2021","journal-title":"Circ Res"},{"key":"B4","first-page":"107","article-title":"Penetrance of familial hypertrophic cardiomyopathy","volume":"8","author":"Charron","year":"1997","journal-title":"Genet Couns Geneva Switz"},{"key":"B5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: a \u03b2 cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0092-8674(94)90054-X","article-title":"\u03b1-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere","volume":"77","author":"Thierfelder","year":"1994","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e001815","DOI":"10.1136\/openhrt-2021-001815","article-title":"Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"9","author":"Christian","year":"2022","journal-title":"Open Heart"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1161\/CIRCGENETICS.111.000032","article-title":"Assigning a causal role to genetic variants in hypertrophic cardiomyopathy","volume":"6","author":"Watkins","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/humu.23757","article-title":"Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype","volume":"40","author":"Kolokotronis","year":"2019","journal-title":"Hum Mutat"},{"key":"B10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-030-27371-2_2","article-title":"The genetic landscape of cardiomyopathies","volume-title":"Genetic causes of cardiac disease.","author":"Gerull","year":"2019"},{"key":"B12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41525-021-00204-w","article-title":"Prognostic implications of troponin T variations in inherited cardiomyopathies using systems biology","volume":"6","author":"Shakur","year":"2021","journal-title":"NJP Genom Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00424-019-02259-2","article-title":"Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations","volume":"471","author":"Spudich","year":"2019","journal-title":"Pfl\u00fcg Arch"},{"key":"B14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","article-title":"Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect","volume":"53","author":"Tadros","year":"2021","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI114802","article-title":"Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease","volume":"86","author":"Solomon","year":"1990","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJM199204233261703","article-title":"Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy","volume":"326","author":"Watkins","year":"1992","journal-title":"N Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCRESAHA.110.223834","article-title":"Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history","volume":"108","author":"Seidman","year":"2011","journal-title":"Circ Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e002460","DOI":"10.1161\/CIRCGEN.119.002460","article-title":"Evaluating the clinical validity of hypertrophic cardiomyopathy genes","volume":"12","author":"Ingles","year":"2019","journal-title":"Circ Genomic Precis Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/gim.2016.90","article-title":"Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples","volume":"19","author":"Walsh","year":"2017","journal-title":"Genet Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10974-020-09592-5","article-title":"A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C","volume":"42","author":"Reinoso","year":"2021","journal-title":"J Muscle Res Cell Motil"},{"key":"B23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1161\/CIRCGENETICS.108.821314","article-title":"Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy","volume":"2","author":"Kaski","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0735-1097(03)00855-6","article-title":"Clinical course of hypertrophiccardiomyopathy with survival to advanced age","volume":"42","author":"Maron","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1136\/hrt.2010.200402","article-title":"Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 spanish families with a single mutation in MYBPC3","volume":"96","author":"Oliva-Sandoval","year":"2010","journal-title":"Heart"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e000929","DOI":"10.1136\/openhrt-2018-000929","article-title":"Heritability in genetic heart disease: the role of genetic background","volume":"6","author":"Jansweijer","year":"2019","journal-title":"Open Heart"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e003704","DOI":"10.1161\/CIRCGEN.122.003704","article-title":"Prevalence and disease expression of pathogenic and likely pathogenic variants associated with inherited cardiomyopathies in the general population","volume":"15","author":"Bourfiss","year":"2022","journal-title":"Circ Genomic Precis Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic expression and outcomes in individuals with rare genetic variants of hypertrophic cardiomyopathy","volume":"78","author":"de Marvao","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e001896","DOI":"10.1161\/CIRCGEN.117.001896","article-title":"Outcomes of contemporary family screening in hypertrophic cardiomyopathy","volume":"11","author":"van Velzen","year":"2018","journal-title":"Circ Genomic Precis Med"},{"key":"B30","author":"Tadros","year":"2023"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e003716","DOI":"10.1161\/CIRCGEN.122.003716","article-title":"Genome-wide analysis of left ventricular maximum wall thickness in the UK biobank cohort reveals a shared genetic background with hypertrophic cardiomyopathy","volume":"16","author":"Aung","year":"2023","journal-title":"Circ Genomic Precis Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0182946","DOI":"10.1371\/journal.pone.0182946","article-title":"Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy","volume":"12","author":"Mendes de Almeida","year":"2017","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41436-018-0046-0","article-title":"Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center","volume":"21","author":"Mazzarotto","year":"2019","journal-title":"Genet Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"630","DOI":"10.4065\/83.6.630","article-title":"Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy","volume":"83","author":"Olivotto","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e001620","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1161\/CIRCULATIONAHA.121.053527","article-title":"Time to think differently about sarcomere-negative hypertrophic cardiomyopathy","volume":"143","author":"Watkins","year":"2021","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41569-021-00608-2","article-title":"Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies","volume":"19","author":"Walsh","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jacc.2009.11.016","article-title":"Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy","volume":"55","author":"Chiu","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/CIRCGENETICS.113.000486","article-title":"Novel \u03b1-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study","volume":"7","author":"Girolami","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/humu.24470","article-title":"Mutation update for the ACTN2 gene","volume":"43","author":"Ranta-aho","year":"2022","journal-title":"Hum Mutat"},{"key":"B44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/cells12050721","article-title":"Insights into the role of a cardiomyopathy-causing genetic variant in ACTN2","volume":"12","author":"Broadway-Stringer","year":"2023","journal-title":"Cells"},{"key":"B45","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jacc.2015.10.093","article-title":"Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy","volume":"67","author":"Almomani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1093\/eurheartj\/ehab424","article-title":"Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy","volume":"42","author":"Lopes","year":"2021","journal-title":"Eur Heart J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"915649","DOI":"10.3389\/fmed.2022.915649","article-title":"The involvement of ALPK3 in hypertrophic cardiomyopathy in East Asia","volume":"9","author":"Dai","year":"2022","journal-title":"Front Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.122.059688","article-title":"Pathogenesis of cardiomyopathy caused by variants in ALPK3, an essential pseudokinase in the cardiomyocyte nucleus and sarcomere","volume":"146","author":"Agarwal","year":"2022","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s44161-023-00219-9","article-title":"Alpha kinase 3 signaling at the M-band maintains sarcomere integrity and proteostasis in striated muscle","volume":"2","author":"McNamara","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e23093","DOI":"10.1002\/jbt.23093","article-title":"MicroRNA-384-5p protects against cardiac hypertrophy via the ALPK3 signaling pathway","volume":"36","author":"Guo","year":"2022","journal-title":"J Biochem Mol Toxicol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.yjmcc.2018.07.248","article-title":"Mutant muscle LIM protein C58G causes cardiomyopathy through protein depletion","volume":"121","author":"Ehsan","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1038\/s41598-022-07553-1","article-title":"LIM domain-wide comprehensive virtual mutagenesis provides structural rationale for cardiomyopathy mutations in CSRP3","volume":"12","author":"Chauhan","year":"2022","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"29873","DOI":"10.1074\/jbc.M109.059303","article-title":"Mammalian formin FHOD3 regulates actin assembly and sarcomere organization in striated muscles","volume":"284","author":"Taniguchi","year":"2009","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","first-page":"E4386","DOI":"10.1073\/pnas.1716498115","article-title":"Interaction between cardiac myosin-binding protein C and formin FHOD3","volume":"115","author":"Matsuyama","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.jacc.2018.10.001","article-title":"Formin homology 2 domain containing 3 (FHOD3) is a genetic basis for hypertrophic cardiomyopathy","volume":"72","author":"Ochoa","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cge.13759","article-title":"Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathy","volume":"98","author":"Ochoa","year":"2020","journal-title":"Clin Genet"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/humu.22942","article-title":"Mutations in FLNC are associated with familial restrictive cardiomyopathy","volume":"37","author":"Brodehl","year":"2016","journal-title":"Hum Mutat"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/humu.24004","article-title":"A mutation update for the FLNC gene in myopathies and cardiomyopathies","volume":"41","author":"Verdonschot","year":"2020","journal-title":"Hum Mutat"},{"key":"B60","doi-asserted-by":"publisher","first-page":"894791","DOI":"10.3389\/fgene.2022.894791","article-title":"Case report: a Chinese family of hypertrophic cardiomyopathy caused by a novel splicing mutation in the FLNC gene","volume":"13","author":"Huang","year":"2022","journal-title":"Front Genet"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/ajmg.a.63169","article-title":"Novel filamin C (FLNC) variant causes a severe form of familial mixed hypertrophic-restrictive cardiomyopathy","volume":"191","author":"Gaudreault","year":"2023","journal-title":"Am J Med Genet A"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2021.11.006","article-title":"One gene, two modes of inheritance, four diseases: a systematic review of the cardiac manifestation of pathogenic variants in JPH2-encoded junctophilin-2","volume":"33","author":"Parker","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"10765","DOI":"10.3390\/ijms231810765","article-title":"Towards a better understanding of genotype\u2013phenotype correlations and therapeutic targets for cardiocutaneous genes: the importance of functional studies above prediction","volume":"23","author":"Vermeer","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/hmg\/ddz032","article-title":"Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24","volume":"28","author":"Hedberg-Oldfors","year":"2019","journal-title":"Hum Mol Genet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e003998","DOI":"10.1161\/CIRCGEN.122.003998","article-title":"Clinical outcome in KLHL24 cardiomyopathy","volume":"16","author":"Vermeer","year":"2023","journal-title":"Circ Genomic Precis Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.yjmcc.2007.06.009","article-title":"Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy","volume":"43","author":"Chiu","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/eurheartj\/ehw603","article-title":"Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes","volume":"38","author":"Walsh","year":"2017","journal-title":"Eur Heart J"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/brain\/awaa206","article-title":"Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuoles","volume":"143","author":"Hedberg-Oldfors","year":"2020","journal-title":"Brain"},{"key":"B69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yjmcc.2013.11.008","article-title":"The role of ubiquitin ligases in cardiac disease","volume":"71","author":"Willis","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/heartjnl-2020-316913","article-title":"Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy","volume":"106","author":"Salazar-Mendiguch\u00eda","year":"2020","journal-title":"Heart"},{"key":"B71","doi-asserted-by":"publisher","first-page":"743472","DOI":"10.3389\/fgene.2022.743472","article-title":"Case report: two new cases of autosomal-recessive hypertrophic cardiomyopathy associated with TRIM63-compound heterozygous variant","volume":"13","author":"Andreeva","year":"2022","journal-title":"Front Genet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/CIRCEP.115.002745","article-title":"Identification and functional characterization of a novel CACNA1C -mediated cardiac disorder characterized by prolonged QT intervals with hypertrophic cardiomyopathy, congenital heart defects, and sudden cardiac death","volume":"8","author":"Boczek","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e1673","DOI":"10.1002\/mgg3.1673","article-title":"Expanding the phenotype of CACNA1C mutation disorders","volume":"9","author":"Gakenheimer-Smith","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"0992","DOI":"10.2169\/internalmedicine.0992-22","article-title":"The myocardial accumulation of aggregated desmin protein in a case of desminopathy with a de novo DES p.R406W mutation","volume":"62","author":"Takegami","year":"2023","journal-title":"Intern Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.cjco.2021.05.003","article-title":"A case report of a rare heterozygous variant in the desmin gene associated with hypertrophic cardiomyopathy and complete atrioventricular block","volume":"3","author":"Oka","year":"2021","journal-title":"CJC Open"},{"key":"B76","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ana.21839","article-title":"Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation","volume":"67","author":"Knoblauch","year":"2010","journal-title":"Ann Neurol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/hmg\/dds157","article-title":"Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy","volume":"21","author":"Friedrich","year":"2012","journal-title":"Hum Mol Genet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1161\/CIRCGENETICS.113.000245","article-title":"Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene","volume":"6","author":"Hartmannova","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCGENETICS.109.862920","article-title":"High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population","volume":"2","author":"Lin","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"B80","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/mgg3.389","article-title":"Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: a multicenter Fabry registry study","volume":"6","author":"Germain","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e002748","DOI":"10.1161\/CIRCGEN.119.002748","article-title":"Genetic testing for diagnosis of hypertrophic cardiomyopathy mimics: yield and clinical significance","volume":"13","author":"Hoss","year":"2020","journal-title":"Circ Genomic Precis Med"},{"key":"B82","doi-asserted-by":"publisher","first-page":"103703","DOI":"10.1016\/j.ejmg.2019.103703","article-title":"Fabry disease caused by the GLA p.Phe113Leu (p.F113l) variant: natural history in males","volume":"63","author":"Oliveira","year":"2020","journal-title":"Eur J Med Genet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e003117","DOI":"10.1161\/CIRCGEN.120.003117","article-title":"Clinical profile of cardiac involvement in danon disease: a multicenter European registry","volume":"13","author":"Lotan","year":"2020","journal-title":"Circ Genomic Precis Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jacc.2020.05.029","article-title":"Clinical features and natural history of PRKAG2 variant cardiac glycogenosis","volume":"76","author":"Lopez-Sainz","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/humu.23535","article-title":"NGS Testing for cardiomyopathy: utility of adding RASopathy-associated genes","volume":"39","author":"Ceyhan-Birsoy","year":"2018","journal-title":"Hum Mutat"},{"key":"B86","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ajmg.a.61072","article-title":"Prevalence of pathogenic and likely pathogenic variants in the RASopathy genes in patients who have had panel testing for cardiomyopathy","volume":"179","author":"Aljeaid","year":"2019","journal-title":"Am J Med Genet A"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nat Genet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"934808","DOI":"10.3389\/fped.2022.934808","article-title":"Noonan syndrome caused by RIT1 gene mutation: a case report and literature review","volume":"10","author":"Zha","year":"2022","journal-title":"Front Pediatr"},{"key":"B89","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/eurheartj\/ehz173","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the transthyretin amyloidosis outcomes survey (THAOS)","volume":"43","author":"Damy","year":"2022","journal-title":"Eur Heart J"},{"key":"B90","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000478900","article-title":"The cumulative effects of the MYH7-V878A and CACNA1C-A1594V mutations in a Chinese family with hypertrophic cardiomyopathy","volume":"138","author":"Wang","year":"2017","journal-title":"Cardiology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1152\/physrev.00024.2022","article-title":"Genome-wide association studies of cardiovascular disease","volume":"103","author":"Walsh","year":"2023","journal-title":"Physiol Rev"},{"key":"B92","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/CIRCGEN.120.002969","article-title":"Categorized genetic analysis in childhood-onset cardiomyopathy","volume":"13","author":"Al-Hassnan","year":"2020","journal-title":"Circ Genomic Precis Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/genes14010182","article-title":"Genetic insights from consanguineous cardiomyopathy families","volume":"14","author":"Maurer","year":"2023","journal-title":"Genes (Basel)"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41431-022-01113-x","article-title":"Recommendations for whole genome sequencing in diagnostics for rare diseases","volume":"30","author":"Souche","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"B95","doi-asserted-by":"publisher","first-page":"100896","DOI":"10.1016\/j.gim.2023.100896","article-title":"Meta-analysis of the diagnostic and clinical utility of exome and genome sequencing in pediatric and adult patients with rare diseases across diverse populations","volume":"25","author":"Chung","year":"2023","journal-title":"Genet Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41431-020-00713-9","article-title":"Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort","volume":"29","author":"Bertoli-Avella","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1097\/CCM.0000000000005052","article-title":"Application of full-spectrum rapid clinical genome sequencing improves diagnostic rate and clinical outcomes in critically ill infants in the China neonatal genomes project*","volume":"49","author":"Wu","year":"2021","journal-title":"Crit Care Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/gim.2018.41","article-title":"Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing","volume":"20","author":"Alfares","year":"2018","journal-title":"Genet Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10557-020-06948-4","article-title":"Advantages and perils of clinical whole-exome and whole-genome sequencing in cardiomyopathy","volume":"34","author":"Mazzarotto","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jacc.2018.04.078","article-title":"Whole genome sequencing improves outcomes of genetic testing in patients with hypertrophic cardiomyopathy","volume":"72","author":"Bagnall","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B101","year":""},{"key":"B102","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1116925","DOI":"10.3389\/fcvm.2023.1116925","article-title":"The role of noncoding genetic variants in cardiomyopathy","volume":"10","author":"Htet","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"957292","DOI":"10.3389\/fcell.2022.957292","article-title":"Understanding the function of regulatory DNA interactions in the interpretation of non-coding GWAS variants","volume":"10","author":"Zhong","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41592-022-01640-x","article-title":"A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies","volume":"19","author":"Li","year":"2022","journal-title":"Nat Methods"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00439-017-1809-4","article-title":"Deep intronic mutations and human disease","volume":"136","author":"Vaz-Drago","year":"2017","journal-title":"Hum Genet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/genes7120133","article-title":"Hybridization capture-based next-generation sequencing to evaluate coding sequence and deep intronic mutations in the NF1 gene","volume":"7","author":"Cunha","year":"2016","journal-title":"Genes (Basel)"},{"key":"B108","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0960-8966(03)00169-X","article-title":"Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene","volume":"14","author":"B\u00e9roud","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"B109","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1086\/301952","article-title":"A novel alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy","volume":"63","author":"Ferlini","year":"1998","journal-title":"Am J Hum Genet"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.nmd.2014.07.003","article-title":"When a mid-intronic variation of DMD gene creates an ESE site","volume":"24","author":"Trabelsi","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"B111","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/humu.23944","article-title":"Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy","volume":"41","author":"Janin","year":"2020","journal-title":"Hum Mutat"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e002905","DOI":"10.1161\/CIRCGEN.120.002905","article-title":"Cryptic splice-altering variants in MYBPC3 are a prevalent cause of hypertrophic cardiomyopathy","volume":"13","author":"Lopes","year":"2020","journal-title":"Circ Genomic Precis Med"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e002783","DOI":"10.1161\/CIRCGEN.119.002783","article-title":"Reevaluation of the south Asian MYBPC3\u039425bp intronic deletion in hypertrophic cardiomyopathy","volume":"13","author":"Harper","year":"2020","journal-title":"Circ Genomic Precis Med"},{"key":"B114","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/ng.309","article-title":"A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia","volume":"41","author":"Dhandapany","year":"2009","journal-title":"Nat Genet"},{"key":"B115","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1086\/339431","article-title":"Alternative splicing in the \u03b1-galactosidase a gene: increased exon inclusion results in the Fabry cardiac phenotype","volume":"70","author":"Ishii","year":"2002","journal-title":"Am J Hum Genet"},{"key":"B116","doi-asserted-by":"publisher","first-page":"780","DOI":"10.2119\/molmed.2012.00002","article-title":"Fabry disease: incidence of the common later-onset \u03b1-galactosidase A IVS4+919G\u2192A mutation in Taiwanese newborns\u2014superiority of DNA-based to enzyme-based newborn screening for common mutations","volume":"18","author":"Chien","year":"2012","journal-title":"Mol Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ymgme.2016.08.007","article-title":"The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2\/B1 to a splicing silencer","volume":"119","author":"Palhais","year":"2016","journal-title":"Mol Genet Metab"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.3390\/ijms13033245","article-title":"Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases","volume":"13","author":"Stuppia","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B119","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ejmg.2015.10.001","article-title":"Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy","volume":"58","author":"Lopes","year":"2015","journal-title":"Eur J Med Genet"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e0181465","DOI":"10.1371\/journal.pone.0181465","article-title":"Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy","volume":"12","author":"Mademont-Soler","year":"2017","journal-title":"PLoS One"},{"key":"B121","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41436-020-00970-5","article-title":"Characterization of clinically relevant copy-number variants from exomes of patients with inherited heart disease and unexplained sudden cardiac death","volume":"23","author":"Singer","year":"2021","journal-title":"Genet Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1016\/j.cell.2022.09.028","article-title":"Influences of rare copy-number variation on human complex traits","volume":"185","author":"Hujoel","year":"2022","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nmeth.1343","article-title":"Filter-based hybridization capture of subgenomes enables resequencing and copy-number detection","volume":"6","author":"Herman","year":"2009","journal-title":"Nat Methods"},{"key":"B124","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/0092-8674(90)90273-H","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: an \u03b1\u03b2 cardiac myosin heavy chain hybrid gene","volume":"62","author":"Tanigawa","year":"1990","journal-title":"Cell"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1172\/JCI116101","article-title":"Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy","volume":"90","author":"Marian","year":"1992","journal-title":"J Clin Invest"},{"key":"B126","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejmg.2012.01.002","article-title":"Molecular characterization of a large MYBPC3 rearrangement in a cohort of 100 unrelated patients with hypertrophic cardiomyopathy","volume":"55","author":"Chanavat","year":"2012","journal-title":"Eur J Med Genet"},{"key":"B127","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.gene.2012.06.097","article-title":"A new mutational mechanism for hypertrophic cardiomyopathy","volume":"507","author":"Pezzoli","year":"2012","journal-title":"Gene"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41431-018-0239-7","article-title":"Analysis of VUS reporting, variant reinterpretation and recontact policies in clinical genomic sequencing consent forms","volume":"26","author":"Vears","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"B129","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jacc.2022.11.036","article-title":"Phenotypes of overdiagnosed long QT syndrome","volume":"81","author":"Bains","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.hrthm.2015.12.008","article-title":"Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome","volume":"13","author":"Gaba","year":"2016","journal-title":"Heart Rhythm"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/biom12101417","article-title":"Next-generation sequencing gene panels in inheritable cardiomyopathies and channelopathies: prevalence of pathogenic variants and variants of unknown significance in uncommon genes","volume":"12","author":"Mazzaccara","year":"2022","journal-title":"Biomolecules"},{"key":"B132","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/heartjnl-2020-316798","article-title":"Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy","volume":"107","author":"Ahluwalia","year":"2021","journal-title":"Heart"},{"key":"B133","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13073-019-0616-z","article-title":"Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy","volume":"11","author":"Walsh","year":"2019","journal-title":"Genome Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2017.26","article-title":"Using high-resolution variant frequencies to empower clinical genome interpretation","volume":"19","author":"Whiffin","year":"2017","journal-title":"Genet Med"},{"key":"B135","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/gim.2017.218","article-title":"Adaptation and validation of the ACMG\/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen\u2019s inherited cardiomyopathy expert panel","volume":"20","author":"Kelly","year":"2018","journal-title":"Genet Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.repc.2020.06.001","article-title":"The challenge of assessing variant pathogenicity in candidate Z-disc genes: the example of TCAP in hypertrophic cardiomyopathy","volume":"39","author":"Lopes","year":"2020","journal-title":"Rev Port Cardiol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"e002368","DOI":"10.1161\/CIRCGEN.118.002368","article-title":"Key value of RNA analysis of MYBPC3 splice-site variants in hypertrophic cardiomyopathy","volume":"12","author":"Singer","year":"2019","journal-title":"Circ Genomic Precis Med"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e1008639","DOI":"10.1371\/journal.pgen.1008639","article-title":"Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy","volume":"16","author":"Manivannan","year":"2020","journal-title":"PLoS Genet"},{"key":"B139","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41436-020-01028-2","article-title":"Autosomal recessive cardiomyopathy and sudden cardiac death associated with variants in MYL3","volume":"23","author":"Osborn","year":"2021","journal-title":"Genet Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1177\/2047487319889714","article-title":"Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy","volume":"27","author":"Park","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCULATIONAHA.118.039132","article-title":"Higher body mass index in adolescence predicts cardiomyopathy risk in midlife: long-term follow-up among Swedish men","volume":"140","author":"Robertson","year":"2019","journal-title":"Circulation"},{"key":"B142","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jamacardio.2022.1061","article-title":"Rare and common genetic variation underlying the risk of hypertrophic cardiomyopathy in a national biobank","volume":"7","author":"Biddinger","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B143","author":"Zheng","year":""},{"key":"B144","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/biof.1555","article-title":"MicroRNAs play an essential role in autophagy regulation in various disease phenotypes","volume":"45","author":"Zhao","year":"2019","journal-title":"BioFactors"},{"key":"B145","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.devcel.2009.10.013","article-title":"A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance","volume":"17","author":"van Rooij","year":"2009","journal-title":"Dev Cell"},{"key":"B146","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s10741-022-10231-z","article-title":"MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkers","volume":"27","author":"Luo","year":"2022","journal-title":"Heart Fail Rev"},{"key":"B147","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.3390\/ijms23073791","article-title":"Circulating miR-499a-5p is a potential biomarker of MYH7-associated hypertrophic cardiomyopathy","volume":"23","author":"Baulina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e010291","DOI":"10.1161\/CIRCHEARTFAILURE.122.010291","article-title":"Circulating MicroRNAs identify early phenotypic changes in sarcomeric hypertrophic cardiomyopathy","volume":"16","author":"Sucharov","year":"2023","journal-title":"Circ Heart Fail"},{"key":"B149","doi-asserted-by":"publisher","first-page":"00085","DOI":"10.1016\/j.tibtech.2023.03.004","article-title":"Prime editing: advances and therapeutic applications","author":"Zhao","year":"2023","journal-title":"Trends Biotechnol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"B151","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41591-022-02176-5","article-title":"Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice","volume":"29","author":"Chai","year":"2023","journal-title":"Nat Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41591-022-02190-7","article-title":"Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in mice","volume":"29","author":"Reichart","year":"2023","journal-title":"Nat Med"},{"key":"B153","doi-asserted-by":"publisher","first-page":"dmm050088","DOI":"10.1242\/dmm.050088","article-title":"Gene editing innovations and their applications in cardiomyopathy research","volume":"16","author":"Kyriakopoulou","year":"2023","journal-title":"Dis Model Mech"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1236539\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T16:51:41Z","timestamp":1690822301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1236539\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":153,"alternative-id":["10.3389\/fcvm.2023.1236539"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1236539","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"article-number":"1236539"}}